Clinical Laserthermia Systems AB (publ)

Informe acción OM:CLS UR B

Capitalización de mercado: SEK 22.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Dirección

Dirección controles de criterios 1/4

We currently do not have sufficient information about the CEO.

Información clave

Dan Mogren

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.6yrs
Participación del CEOn/a
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directiva3yrs

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates

No hay actualizaciones

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Dan Mogren en comparación con los beneficios de Clinical Laserthermia Systems?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022n/an/a

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensación vs. Mercado: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensación vs. Ingresos: Insufficient data to compare Dan's compensation with company performance.

CEO

Dan Mogren

2.6yrs

Permanencia

SEK 1,551,882

Compensación

Mr. Dan J. Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief Commer...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Dan Mogren
Chief Executive Officer2.6yrsSEK 1.55msin datos
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 1.65msin datos
Rolf Bornschein
Chief Financial Officerless than a yearsin datossin datos
Jimmy Johansson
Executive Vice President of Operationsless than a yearsin datossin datos
Stephan Dymling
Head of Technical Developmentno datasin datossin datos
Karin Peterson
Chief Product Officerno datasin datossin datos
Mats Ekelund
Chief Medical Officerno datasin datossin datos

0.8yrs

Permanencia media

Equipo directivo experimentado: CLS UR B's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Lars-Erik Eriksson
Co-Founder & Director17.5yrsSEK 1.65msin datos
Hans von Celsing
Independent Chairman of the Board10.5yrsSEK 285.00k0.22%
SEK 48.9k
Gunilla Savring
Independent Director3.5yrsSEK 142.50ksin datos
Rolf Kiessling
Member of Clinical Advisory Board2.1yrsSEK 80.00ksin datos
Karl-Göran Tranberg
Member of Clinical Advisory Board2.1yrsSEK 80.00k0.90%
SEK 200.9k
Paolo Raffaelli
Independent Director2.5yrsSEK 62.50ksin datos
Marika Crohns
Independent Director & Member of Clinical Advisory Board3.5yrsSEK 142.50ksin datos
Sandy Brandmeier
Independent Director2.5yrssin datossin datos

3.0yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: CLS UR B's board of directors are considered experienced (3 years average tenure).